A Clinical Trial With KJ103 in Anti-GBM Disease

NCT06607016 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Glomerular Basement Membrane Disease

Interventions

DRUG: KJ103 for Injection
DRUG: Cyclophosphamide
DRUG: Glucocorticoids
PROCEDURE: Plasma exchange (PE)

Sponsor

Shanghai Bao Pharmaceuticals Co., Ltd.